- Home
- PEPG vs SRTS Comparison
PEPG vs SRTS Comparison
Compare PEPG & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- SRTS
- Stock Information
- Founded
- PEPG 2018
- SRTS 2010
- Country
- PEPG United States
- SRTS United States
- Employees
- PEPG N/A
- SRTS N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- SRTS Medical/Dental Instruments
- Sector
- PEPG Health Care
- SRTS Health Care
- Exchange
- PEPG Nasdaq
- SRTS Nasdaq
- Market Cap
- PEPG 118.3M
- SRTS 110.3M
- IPO Year
- PEPG 2022
- SRTS 2016
- Fundamental
- Price
- PEPG $2.08
- SRTS $6.84
- Analyst Decision
- PEPG Buy
- SRTS Strong Buy
- Analyst Count
- PEPG 3
- SRTS 2
- Target Price
- PEPG $14.67
- SRTS $12.50
- AVG Volume (30 Days)
- PEPG 158.0K
- SRTS 236.2K
- Earning Date
- PEPG 03-05-2025
- SRTS 02-06-2025
- Dividend Yield
- PEPG N/A
- SRTS N/A
- EPS Growth
- PEPG N/A
- SRTS N/A
- EPS
- PEPG N/A
- SRTS 0.57
- Revenue
- PEPG N/A
- SRTS $41,308,000.00
- Revenue This Year
- PEPG N/A
- SRTS $65.04
- Revenue Next Year
- PEPG N/A
- SRTS $24.87
- P/E Ratio
- PEPG N/A
- SRTS $12.02
- Revenue Growth
- PEPG N/A
- SRTS 65.62
- 52 Week Low
- PEPG $2.09
- SRTS $2.91
- 52 Week High
- PEPG $19.30
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- PEPG 18.60
- SRTS 43.96
- Support Level
- PEPG $3.69
- SRTS $6.53
- Resistance Level
- PEPG $4.48
- SRTS $6.93
- Average True Range (ATR)
- PEPG 0.27
- SRTS 0.38
- MACD
- PEPG -0.09
- SRTS -0.00
- Stochastic Oscillator
- PEPG 0.25
- SRTS 37.10
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.